Ascent Study News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Shay Elkins, a patient with metastatic triple-negative breast cancer, discussed her experience with second-line treatment. Dr. Noor provided insights into the positive outcomes from the ASCENT study.

Metastatic triple negative breast cancerOvercoming challengesDiagnosis treatmentSacituzumab govitecanTriple negative breast cancerSecond line optionsTherapy concernsSide effectsQuality of lifeTreatment goalsAscent studyProgression free survivalOverall survivalObjective response rateFda approvalEarly treatment